Summary:
- Researchers at the Weizmann Institute of Science have identified a novel mechanism involving the immune system's "memory" that contributes to the chronic nature of inflammatory bowel disease (IBD).
- The study reveals how specific immune cells in the gut retain a molecular "memory" of previous inflammation, causing them to respond more aggressively to subsequent triggers and preventing the tissue from fully healing.
- This discovery highlights a potential therapeutic target, suggesting that by resetting or inhibiting these memory-like immune cells, it may be possible to induce long-term remission in patients suffering from IBD.